(Total Views: 644)
Posted On: 01/08/2021 12:01:26 AM
Post# of 153905
“I’m assuming this has to do with IP rights and not just ego (as some have suggested).”
Likely a little of both. Incelldx filed a patent for the CCR5/CCL5 treatment pathway before the paper was submitted for approval, likely upsetting NP and the rest of CYDY. The link to the patent is below. Similar patents were filed and approved for the CCR5 treatment pathway of cancer by Dr. Pestell and if I remember correctly, were part of the Prostagene deal.
http://appft.uspto.gov/netacgi/nph-Parser?Sec...S=Incelldx
Likely a little of both. Incelldx filed a patent for the CCR5/CCL5 treatment pathway before the paper was submitted for approval, likely upsetting NP and the rest of CYDY. The link to the patent is below. Similar patents were filed and approved for the CCR5 treatment pathway of cancer by Dr. Pestell and if I remember correctly, were part of the Prostagene deal.
http://appft.uspto.gov/netacgi/nph-Parser?Sec...S=Incelldx
(1)
(0)
